TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Olink Proteomics AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,382,259
|
1,473,511
|
1,357,752 |
| Financial expenses |
13,636
|
48,814
|
4,735 |
| Earnings before taxes |
-516,162
|
-90,059
|
4,584 |
| EBITDA |
-518,882
|
-14,957
|
24,396 |
| Total assets |
1,690,919
|
1,875,073
|
1,256,042 |
| Current assets |
782,348
|
1,067,080
|
908,758 |
| Current liabilities |
579,540
|
283,799
|
878,179 |
| Equity capital |
1,111,379
|
1,591,274
|
377,863 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
394
|
362
|
289 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
65.7%
|
84.9%
|
30.1% |
| Turnover per employee |
3,508
|
4,070
|
4,698 |
| Profit as a percentage of turnover |
-37.3%
|
-6.1%
|
0.3% |
| Return on assets (ROA) |
-29.7%
|
-2.2%
|
0.7% |
| Current ratio |
135.0%
|
376.0%
|
103.5% |
| Return on equity (ROE) |
-46.4%
|
-5.7%
|
1.2% |
| Change turnover |
-91,252
|
115,759
|
577,665 |
| Change turnover % |
-6%
|
9%
|
74% |
| Chg. No. of employees |
32
|
73
|
106 |
| Chg. No. of employees % |
9%
|
25%
|
58% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.